Establishment Labs Holdings Inc (NASDAQ:ESTA) Major Shareholder Jw Asset Management, Llc Buys 1,000 Shares of Stock

Establishment Labs Holdings Inc (NASDAQ:ESTA) major shareholder Jw Asset Management, Llc bought 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 20th. The stock was acquired at an average cost of $20.00 per share, for a total transaction of $20,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Jw Asset Management, Llc also recently made the following trade(s):

  • On Friday, August 16th, Jw Asset Management, Llc bought 2,000 shares of Establishment Labs stock. The stock was acquired at an average cost of $21.42 per share, for a total transaction of $42,840.00.
  • On Monday, August 12th, Jw Asset Management, Llc bought 3,000 shares of Establishment Labs stock. The stock was acquired at an average cost of $22.15 per share, for a total transaction of $66,450.00.
  • On Wednesday, July 31st, Jw Asset Management, Llc bought 1,500 shares of Establishment Labs stock. The stock was acquired at an average cost of $25.31 per share, for a total transaction of $37,965.00.
  • On Monday, July 29th, Jw Asset Management, Llc acquired 2,500 shares of Establishment Labs stock. The stock was bought at an average price of $25.58 per share, with a total value of $63,950.00.

ESTA traded up $0.09 on Thursday, hitting $21.05. The company had a trading volume of 378 shares, compared to its average volume of 90,082. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.94 and a quick ratio of 2.70. Establishment Labs Holdings Inc has a 52-week low of $19.61 and a 52-week high of $30.70. The stock has a fifty day simple moving average of $22.77 and a 200-day simple moving average of $24.29. The firm has a market capitalization of $410.00 million and a P/E ratio of -18.72.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.44) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.52) by $0.08. Establishment Labs had a negative net margin of 38.63% and a negative return on equity of 60.43%. The business had revenue of $21.68 million during the quarter, compared to analyst estimates of $20.10 million. Equities research analysts expect that Establishment Labs Holdings Inc will post -1.97 earnings per share for the current fiscal year.

Several analysts have commented on ESTA shares. ValuEngine upgraded shares of Establishment Labs from a “hold” rating to a “buy” rating in a report on Monday, July 29th. BTIG Research restated a “buy” rating and issued a $40.00 price objective on shares of Establishment Labs in a report on Thursday, May 16th. Stephens started coverage on shares of Establishment Labs in a report on Thursday, June 6th. They issued an “overweight” rating and a $37.00 price objective for the company. Wells Fargo & Co set a $29.00 price objective on shares of Establishment Labs and gave the stock a “buy” rating in a report on Friday, July 12th. Finally, Zacks Investment Research lowered shares of Establishment Labs from a “hold” rating to a “sell” rating in a report on Friday, August 16th. One analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $35.33.

Institutional investors and hedge funds have recently modified their holdings of the business. Wells Fargo & Company MN acquired a new stake in Establishment Labs during the second quarter valued at $479,000. JPMorgan Chase & Co. grew its position in Establishment Labs by 96.3% during the second quarter. JPMorgan Chase & Co. now owns 13,014 shares of the company’s stock valued at $273,000 after buying an additional 6,386 shares during the period. JW Asset Management LLC grew its position in Establishment Labs by 1,840.3% during the second quarter. JW Asset Management LLC now owns 3,104,485 shares of the company’s stock valued at $68,268,000 after buying an additional 2,944,485 shares during the period. Tower Research Capital LLC TRC grew its position in Establishment Labs by 257.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,350 shares of the company’s stock valued at $30,000 after buying an additional 972 shares during the period. Finally, Vanguard Group Inc. acquired a new stake in Establishment Labs during the second quarter valued at $349,000. Institutional investors and hedge funds own 25.86% of the company’s stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue.

Further Reading: Growth and Income Funds

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.